Veru Inc Stock Today
VERU Stock | USD 0.49 0.01 1.15% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Veru is selling for under 0.4855 as of the 17th of March 2025; that is 1.15 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.45. Veru has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Household & Personal Products | IPO Date 19th of July 1990 | Category Healthcare | Classification Consumer Staples |
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Veru operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 146.38 M outstanding shares of which 15 M shares are at this time shorted by private and institutional investors with about 3.95 trading days to cover. More on Veru Inc
Moving against Veru Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Veru Stock Highlights
President Chairman | MD FACS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Personal Care Products, Household & Personal Products, Consumer Staples, NASDAQ Composite, Pharmaceutical Products, Consumer Staples, Personal Care Products, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsVeru can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Veru's financial leverage. It provides some insight into what part of Veru's total assets is financed by creditors.
|
Veru Inc (VERU) is traded on NASDAQ Exchange in USA. It is located in 2916 North Miami Avenue, Miami, FL, United States, 33127 and employs 210 people. Veru is listed under Personal Care Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 70.91 M. Veru Inc conducts business under Personal Care Products sector and is part of Consumer Staples industry. The entity has 146.38 M outstanding shares of which 15 M shares are at this time shorted by private and institutional investors with about 3.95 trading days to cover.
Veru Inc currently holds about 100.55 M in cash with (21.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Veru Probability Of Bankruptcy
Ownership AllocationVeru Inc shows a total of 146.38 Million outstanding shares. 30% of Veru Inc outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Veru Ownership Details
Veru Stock Institutional Holders
Instituion | Recorded On | Shares | |
Cambridge Invest Research Advisors, Inc. | 2024-12-31 | 1.2 M | |
Oppenheimer & Co Inc | 2024-12-31 | 1.1 M | |
Exome Asset Management Llc | 2024-12-31 | 1.1 M | |
Deutsche Bank Ag | 2024-12-31 | 1.1 M | |
Northern Trust Corp | 2024-12-31 | 1 M | |
Ikarian Capital, Llc | 2024-12-31 | 945.2 K | |
Ubs Group Ag | 2024-12-31 | 448.6 K | |
Citadel Advisors Llc | 2024-12-31 | 412.8 K | |
Envestnet Asset Management Inc | 2024-12-31 | 406.8 K | |
Blackrock Inc | 2024-12-31 | 8.3 M | |
Perceptive Advisors Llc | 2024-12-31 | 6.5 M |
Veru Historical Income Statement
Veru Stock Against Markets
Veru Corporate Management
MB LLB | Executive Sales | Profile | |
Gary Barnette | Chief Officer | Profile | |
Gary Bird | Executive Affairs | Profile | |
Jason Davies | Europe, UK | Profile | |
Philip JD | Executive Counsel | Profile | |
FACS FACS | Pres Chairman | Profile |
Additional Tools for Veru Stock Analysis
When running Veru's price analysis, check to measure Veru's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veru is operating at the current time. Most of Veru's value examination focuses on studying past and present price action to predict the probability of Veru's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veru's price. Additionally, you may evaluate how the addition of Veru to your portfolios can decrease your overall portfolio volatility.